ArticleHardwareX2022
Low cost, non-invasive, and continuous vital signs monitoring device for pregnant women in low resource settings (Lvital device).
Article in HardwareX, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 15 citations in OpenAlex.
- Parental perceptions of a wearable vital signs monitor for observation of newborns: in-depth interviews in three tertiary hospitals, Southwest Nigeria.Frontiers in digital health · 2025Article
- Pathological Insights: Enhanced Vision Transformers for the Early Detection of Colorectal Cancer.Cancers · 2024Article
- Vision-Transformer-Based Transfer Learning for Mammogram Classification.Diagnostics (Basel, Switzerland) · 2023Article
- Evaluation of a New Smartphone Powered Low-cost Pulse Oximeter Device.Ethiopian journal of health sciences · 2022Article
- Development of Low-Cost and Portable Pulse Oximeter Device with Improved Accuracy and Accessibility.Medical devices (Auckland, N.Z.) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Around 800 women die each day from complications of pregnancy and childbirth in the world. Vital Signs monitoring (such as blood pressure, pulse rate, and temperature) are among fundamental parameters of ensuring the health and safety of women and newborns during pregnancy, labor, and childbirth. Approximately, 10% of women experience hypertension (greater than140/90) during pregnancy. High blood pressure during pregnancy can cause extra stress on the heart and kidneys and can increase the risk of heart disease. Therefore, early recognition of abnormal vital signs, which are induced due to pregnancy can allow for timely identification of clinical deterioration. Currently used technologies are expensive and complex design with implementation challenges in low-resource settings where maternal morbidity and mortality is higher. Thus, considering the above need, here a hardware device has been designed and developed, which is a low cost, and portable for pregnant women's vital signs (with cuff-less blood pressure, heart rate, and body temperature) monitoring device. The developed device would have a remarkable benefit of monitoring the maternal vital signs especially for those in low resource settings, where there is a high paucity of vital signs monitoring devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.